Scholarly Works

In rifampicin-resistant TB, bedaquiline-containing...

Journal article

In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Infectious Disease: [Formula: see text] Pulmonology: [Formula: see text].

Authors

Nachman A; Chagla Z

Journal

Annals of Internal Medicine, Vol. 178, No. 2,

Publisher

American College of Physicians

Publication Date

February 1, 2025

DOI

10.7326/annals-24-03918-jc

ISSN

1056-8751

Associated Experts

Zain Chagla

Associate Professor, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences

Sustainable Development Goals (SDG)

3 Good Health and Well Being

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback